57 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
or protection of human health and the environment (“Environmental Law”), except for violations and liabilities which, individually or in the aggregate, could … at, onto or from any such property or into the environment surrounding any such property of any Hazardous Substances with respect to which
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
, local and foreign laws, rules, regulations, decisions and orders relating to pollution or protection of human health and safety, the environment
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
pronouncements or changes in our accounting policies; and
the changing and volatile global economic environment.
The cumulative effects
424B5
o17o6adttv
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
mxggg91jfbfc449sak
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-1.1
96u12ajl
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
d8wjm6dkvz7j5 oauya
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
7d9myic lgx
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
71cyyumwe4
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
d93who2gbij l1oz
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm